Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned Vitabiotics

Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned Vitabiotics

Mumbai: Indian drugmaker Lupin and a clutch of private equity investors including EQT Partners and TPG Capital are in separate early-stage discussions to acquire UK’s largest nutraceutical company, Vitabiotics, people aware of the development said. The potential deal is expected to value the Lalvani family-owned business at around £1 billion (`11,800 crore). Lupin is in…

Read More